117 related articles for article (PubMed ID: 10506931)
21. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
22. Expression of Thomsen-Friedenreich (TF) antigens on lymphocytes. II. Loss of cryptic TF antigens during mitogenic activation of human T and B lymphocytes.
Wolf MF; Schmitt HR; Schumacher K
Cell Immunol; 1989 Jul; 121(2):366-71. PubMed ID: 2786763
[TBL] [Abstract][Full Text] [Related]
23. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
[TBL] [Abstract][Full Text] [Related]
24. Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): role of epitope masking by glycans.
Cao Y; Karsten U
Histochem Cell Biol; 2001 Apr; 115(4):349-56. PubMed ID: 11405064
[TBL] [Abstract][Full Text] [Related]
25. Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation.
Irazoqui FJ; Jansson B; Lopez PH; Nores GA
J Biochem; 2001 Jul; 130(1):33-7. PubMed ID: 11432777
[TBL] [Abstract][Full Text] [Related]
26. Expression of mucin-associated carbohydrate core antigens in esophageal squamous cell carcinomas.
Flucke U; Zirbes TK; Schröder W; Mönig SP; Koch V; Schmitz K; Thiele J; Dienes HP; Hölscher AH; Baldus SE
Anticancer Res; 2001; 21(3C):2189-93. PubMed ID: 11501845
[TBL] [Abstract][Full Text] [Related]
27. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival.
Kurtenkov O; Klaamas K; Mensdorff-Pouilly S; Miljukhina L; Shljapnikova L; Chuzmarov V
Acta Oncol; 2007; 46(3):316-23. PubMed ID: 17450466
[TBL] [Abstract][Full Text] [Related]
28. Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study.
Cao Y; Stosiek P; Springer GF; Karsten U
Histochem Cell Biol; 1996 Aug; 106(2):197-207. PubMed ID: 8877380
[TBL] [Abstract][Full Text] [Related]
29. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.
Yu LG; Andrews N; Zhao Q; McKean D; Williams JF; Connor LJ; Gerasimenko OV; Hilkens J; Hirabayashi J; Kasai K; Rhodes JM
J Biol Chem; 2007 Jan; 282(1):773-81. PubMed ID: 17090543
[TBL] [Abstract][Full Text] [Related]
30. Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.
Langkilde NC; Wolf H; Clausen H; Orntoft TF
Cancer Res; 1992 Sep; 52(18):5030-6. PubMed ID: 1516058
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and immunological evaluation of the unnatural β-linked mucin-1 Thomsen-Friedenreich conjugate.
Wu X; McFall-Boegeman H; Rashidijahanabad Z; Liu K; Pett C; Yu J; Schorlemer M; Ramadan S; Behren S; Westerlind U; Huang X
Org Biomol Chem; 2021 Mar; 19(11):2448-2455. PubMed ID: 33645601
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the role of type 1 core O-glycans in the binding of anti-MUC1 antibodies by cytofluorometry and synthetic peptide/glycopeptide binding inhibition studies.
Reddish MA; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker BM
Tumour Biol; 1998; 19 Suppl 1():57-66. PubMed ID: 9422089
[TBL] [Abstract][Full Text] [Related]
33. Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.
Rodriguez MC; Yegorova S; Pitteloud JP; Chavaroche AE; André S; Ardá A; Minond D; Jiménez-Barbero J; Gabius HJ; Cudic M
Biochemistry; 2015 Jul; 54(29):4462-74. PubMed ID: 26129647
[TBL] [Abstract][Full Text] [Related]
34. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
Kodar K; Izotova J; Klaamas K; Sergeyev B; Järvekülg L; Kurtenkov O
World J Gastroenterol; 2013 Jun; 19(23):3573-82. PubMed ID: 23801858
[TBL] [Abstract][Full Text] [Related]
35. Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation.
Böhm CM; Mulder MC; Zennadi R; Notter M; Schmitt-Gräff A; Finn OJ; Taylor-Papadimitriou J; Stein H; Clausen H; Riecken EO; Hanski C
Scand J Immunol; 1997 Jul; 46(1):27-34. PubMed ID: 9246205
[TBL] [Abstract][Full Text] [Related]
36. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
Seko A; Ohkura T; Ideo H; Yamashita K
Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
[TBL] [Abstract][Full Text] [Related]
37. Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedenreich antigen-binding lectins.
Yu LG; Milton JD; Fernig DG; Rhodes JM
J Cell Physiol; 2001 Feb; 186(2):282-7. PubMed ID: 11169464
[TBL] [Abstract][Full Text] [Related]
38. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen.
Karsten U; Butschak G; Cao Y; Goletz S; Hanisch FG
Hybridoma; 1995 Feb; 14(1):37-44. PubMed ID: 7539400
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
[TBL] [Abstract][Full Text] [Related]
40. The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding.
Jeschke U; Walzel H; Mylonas I; Papadopoulos P; Shabani N; Kuhn C; Schulze S; Friese K; Karsten U; Anz D; Kupka MS
J Histochem Cytochem; 2009 Sep; 57(9):871-81. PubMed ID: 19506091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
